These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4317645)

  • 1. [Some data from a biochemical study of patients with primary cancer of the liver during chemotherapy].
    Pashintseva LP; Krusanova NI; Assekritova IV
    Vestn Akad Med Nauk SSSR; 1970; 25(2):39-43. PubMed ID: 4317645
    [No Abstract]   [Full Text] [Related]  

  • 2. Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: implication in 5-fluorouracil-based chemotherapy.
    Jiang W; Lu Z; He Y; Diasio RB
    Clin Cancer Res; 1997 Mar; 3(3):395-9. PubMed ID: 9815697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical profile in liver cancer patients.
    Rasheed A; Iqtidar A
    Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):366-7. PubMed ID: 7668112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of combined hepatocellular and cholangiocarcinoma showing tumor growth and invasion to the diaphragm during interferon-alpha and 5-fluorouracil combined intra-arterial chemotherapy].
    Noda T; Nagano H; Marubashi S; Kobayashi S; Takeda Y; Murakami M; Tomimaru Y; Dono K; Umeshita K; Nakayama M; Shima T; Wakasa K; Monden M; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2099-102. PubMed ID: 19106536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous prolonged intrahepatic infusion of 5-fluorouracil in the treatment of hepatoma in Ibadan.
    Francis TI
    West Afr Med J Niger Pract; 1972 Feb; 21(1):18-20. PubMed ID: 4338412
    [No Abstract]   [Full Text] [Related]  

  • 6. [Selective chemotherapy of hepatocellular carcinomas].
    Keppler D; Pausch J; Gerok W
    Verh Dtsch Ges Inn Med; 1978; (84):606-10. PubMed ID: 217196
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatocellular carcinoma responding to chemotherapy with 5-FU.
    Yoshida H; Onda M; Tajiri T; Umehara M; Mamada Y; Taniai N; Kaneko M; Mizuguchi Y; Uchida E; Yamashita K; Uchida E
    Hepatogastroenterology; 2000; 47(34):1120-1. PubMed ID: 11020893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial.
    Kawata S; Yamasaki E; Nagase T; Inui Y; Ito N; Matsuda Y; Inada M; Tamura S; Noda S; Imai Y; Matsuzawa Y
    Br J Cancer; 2001 Apr; 84(7):886-91. PubMed ID: 11286466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Apropos of a hepatoma: rôle of regional chemotherapy].
    Bessot M; Thevenin F; Fays J; Grilliat JP
    Sem Hop; 1968 Jun; 44(29):1995-6. PubMed ID: 4299982
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolonged survival with hepatocellular carcinoma.
    Penalba C; Larouze B; Mechali D; Saimot G; Coulaud JP
    Gastroenterology; 1982 Nov; 83(5):1159. PubMed ID: 6288508
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatoma: long-term survival with disseminated tumor treated with 5-fluorouracil.
    Ramirez G; Ansfield FJ; Curreri AR
    Am J Surg; 1970 Sep; 120(3):400-3. PubMed ID: 4318569
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma.
    Ueno H; Okada S; Okusaka T; Ikeda M; Kuriyama H
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):155-60. PubMed ID: 11862430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of adriamycin in hepatoma patients with cirrhosis.
    Chan KK; Chlebowski RT; Tong M; Chen HS; Gross JF; Bateman JR
    Cancer Res; 1980 Apr; 40(4):1263-8. PubMed ID: 6244090
    [No Abstract]   [Full Text] [Related]  

  • 14. Embryo extracts opotherapy reduces alpha-fetoprotein levels in hepatocellular carcinoma patients.
    Franchi F; Ielapi T; Bizzarri M; Seminara P
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1467-8. PubMed ID: 16105144
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sequential changes in blood concentrations of tegafur and 5-FU during oral administration of fine granules of tegafur in patients with primary liver cancer].
    Onji M; Yamashita Y; Horiike N; Kanaoka M; Ohta Y; Yoshida T; Hattori M
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):480-8. PubMed ID: 6307183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma.
    Tanioka H; Tsuji A; Morita S; Horimi T; Takamatsu M; Shirasaka T; Mizushima T; Ochi K; Kiura K; Tanimoto M
    Anticancer Res; 2003; 23(2C):1891-7. PubMed ID: 12820474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma.
    Cochrane AM; Murray-Lyon IM; Brinkley DM; Williams R
    Cancer; 1977 Aug; 40(2):609-14. PubMed ID: 196734
    [No Abstract]   [Full Text] [Related]  

  • 18. Th1/Th2 balance: an important indicator of efficacy for intra-arterial chemotherapy.
    Nagai H; Miyaki D; Matsui T; Kanayama M; Higami K; Momiyama K; Ikehara T; Watanabe M; Sumino Y; Miki K
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):959-63. PubMed ID: 18259753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen).
    Boucher E; Corbinais S; Brissot P; Boudjema K; Raoul JL
    Cancer Chemother Pharmacol; 2002 Oct; 50(4):305-8. PubMed ID: 12357305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of selective administration of anticancer agents in massive dosage combined with fibrolytic enzyme (urokinase) in hepatic cancer].
    Daido R; Koike A; Nomiyama Y; Nakamura M; Watanabe T
    Gan No Rinsho; 1972 Apr; 18(4):285-9. PubMed ID: 4337719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.